Results 71 to 80 of about 214,611 (264)

From Cell‐Derived Vesicles to Hybrid Nanovectors: Biological Membranes as Functional Blueprints for Gene Delivery

Advanced Healthcare Materials, EarlyView.
Biologically derived and hybrid nonviral nanovectors are examined as distinct but convergent design approaches. Integrating synthetic components with biologically functionalized membranes allows efficient interactions with complex cellular environments.
Clara Baldari, Claudia Leone, Gabriella Leccese, Claudia De Stradis, Alessandra Invidia, Concetta Quintarelli, Biagio De Angelis, Franco Locatelli, Giuseppe Gigli, Gabriele Maiorano, Ilaria Elena Palamà   +10 more
wiley   +1 more source

Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review

, 2023
Jin Wang,1– 3,* Dongying Liao,1– 3,* Xuemin Zhang,1– 3 Changhong Miao,1– 3 Kuang Chen1– 3 1Department of Emergency, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, People’s Republic of China ...
Chen K, Zhang X, Miao C, Liao D, Wang J
core  

Advances in 3D Bioprinting for Breast Cancer Modeling: Tumor Microenvironment, Metastasis, and Drug Screening

Advanced Healthcare Materials, EarlyView.
Three‐dimensional bioprinting transforms breast cancer modeling from simple constructs into spatially organized, multicellular, perfused, and patient‐derived platforms. This review shows how bioinks, cellular composition, architecture, and flow govern tumor behavior and drug response, while revealing why complexity alone is insufficient without ...
Mustafa Nakipoglu, Mahboobeh Mahmoodi, Ehsanul Hoque Apu, Fahimeh Shahabipour, Sibel Emir Diltemiz, Sanjib Saha, Halima Alem, Nureddin Ashammakhi   +7 more
wiley   +1 more source

Evaluation of HER2 status in breast cancer: comparison between traditional methods and molecular analysis.

, 2023
reservedIl carcinoma della mammella è una patologia estremamente eterogenea classificabile in sottotipi che differiscono in termini di rischio complessivo e risposta farmacologica.
BOCCADIFUOCO, CHIARA
core  

Membrane‐Bound Multimodal Plasmonic Transducers for Noninvasive, In Situ Monitoring and Control of CAR T Cells Against Heterogeneous Solid Tumors

Advanced Materials, EarlyView.
Membrane‐bound multimodal transducers enable longitudinal ultrasound‐guided photoacoustic monitoring and in situ thermal control of CAR T cells in heterogeneous solid tumors. Imaging correlates T cell trafficking with tumor response, distinguishing responders from nonresponders.
Myeongsoo Kim, Ali Zamat, Melissa Cadena, Chloé Thiveaud, Riya Sen, Jeungyoon Lee, Elif Kulaksizoglu, S. Abbey Oliver, Don VanderLaan, Sydney Fábrega, Zizhen Zha, Kelsey P. Kubelick, Jinhwan Kim, Gabriel A. Kwong, Stanislav Y. Emelianov   +14 more
wiley   +1 more source

Her2-FISH analysis of DTCs from breast cancer patient BM.

, 2017
Top Row: DTC with normal copy number of CEP17 and Her2. Bottom Row: DTC with normal copy number of CEP17 and increased copy number of Her2.
Pete Amstutz (3700855), Cha-Mei Tang (3421535), Rebecca L. Aft (2424340), Shuhong Li (151480), Olga V. Makarova (259232), Sreeraj G. Pillai (3700864), Peixuan Zhu (3493613), Chidananda M. Siddappa (3700852), Daniel L. Adams (3700858), Ryan Nunley (3700861), Mark A. Watson (1276500)   +10 more
core   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

Advanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng, Yuxue Cao, Maria Kavallaris, Taskeen Janjua, Amirali Popat   +4 more
wiley   +1 more source

A Novel Immunotoxin Based on BmK AGAP Toxin for HER2-Positive Breast Cancer: An In Silico Study [PDF]

Journal of Mazandaran University of Medical Sciences
Background and purpose: Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide. The HER2 protein, an epidermal growth factor receptor, is overexpressed in approximately 25% of breast cancer cases, making it a key ...
Sadaf Azdoo, Samira Mokhtari, Navid Nezafat, Farzaneh Vahedi, Mortaza Taheri-Anganeh, Khadijeh Ahmadi, Mehdi Alizadeh, Seyyed Hossein Khatami, Mohamad Sabaghan, Rahmatollah Soltani, Vahid Zarezade, Ahmad Movahedpour, Hassan Ghasemi   +12 more
doaj  

KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer – practical implications for the clinician

Radiology and Oncology, 2019
Colorectal cancer is a successful model of genetic biomarker development in oncology. Currently, several predictive or prognostic genetic alterations have been identified and are used in clinical practice.
Afrăsânie Vlad-Adrian, Marinca Mihai Vasile, Alexa-Stratulat Teodora, Gafton Bogdan, Păduraru Marius, Adavidoaiei Anca Maria, Miron Lucian, Rusu Cristina   +7 more
doaj   +1 more source

Breast cancer receptor status assessment and clinicopathological association in Nigerian women: A retrospective analysis [PDF]

, 2014
Background: Breast cancer markers are becoming increasingly important in breast cancer research due to their impact on prognosis, treatment and survival.
Ayodele, Sanni D., Javid, Farideh A., Popoola, Abiodun O., Oludara, Mobolaji A, Obafunwa, John O., Makanjuola, Samira B.L.   +5 more
core   +1 more source